Clinical Trial Update: DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis [Phase 2]

View source ↗

Summary

Phase 2 trial of DaxibotulinumtoxinA for plantar fasciitis was terminated; results posted but no further development details provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plantar Fasciitis

Drugs mentioned

• DaxibotulinumtoxinA for Injection (daxibotulinumtoxinA)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Plantar Fasciitis | Phase 2 | Status: TERMINATED | Results posted: 2024-04-03